Jeffrey Vest

1.1k total citations
7 papers, 278 citations indexed

About

Jeffrey Vest is a scholar working on Surgery, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Jeffrey Vest has authored 7 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Economics and Econometrics and 2 papers in Epidemiology. Recurrent topics in Jeffrey Vest's work include Lipoproteins and Cardiovascular Health (3 papers), Pharmaceutical Economics and Policy (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Jeffrey Vest is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Pharmaceutical Economics and Policy (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Jeffrey Vest collaborates with scholars based in United States, South Africa and India. Jeffrey Vest's co-authors include Robert W. Mays, Cathy Sila, Souvik Sen, Sean I. Savitz, Ken Uchino, David Chiu, Gary A. Ford, David C. Hess, Lawrence R. Wechsler and David S. Liebeskind and has published in prestigious journals such as Circulation, Gastroenterology and The Lancet Neurology.

In The Last Decade

Jeffrey Vest

6 papers receiving 273 citations

Peers

Jeffrey Vest
Kate Xie United States
Pilar Piñero Spain
Magdalena Carmona Spain
Julia Billigen United States
Maurício Friedrich Brazil
Xiaopei Xi United States
Kelsey Duncan United States
Tongchao Geng China
Katsuhiko Maruichi Japan
Mohammad Reza Motamed Iran
Kate Xie United States
Jeffrey Vest
Citations per year, relative to Jeffrey Vest Jeffrey Vest (= 1×) peers Kate Xie

Countries citing papers authored by Jeffrey Vest

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Vest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Vest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Vest more than expected).

Fields of papers citing papers by Jeffrey Vest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Vest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Vest. The network helps show where Jeffrey Vest may publish in the future.

Co-authorship network of co-authors of Jeffrey Vest

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Vest. A scholar is included among the top collaborators of Jeffrey Vest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Vest. Jeffrey Vest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
Raal, Frederick J., Vimal Mehta, Meral Kayıkçıoğlu, et al.. (2025). Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial. The Lancet Diabetes & Endocrinology. 13(3). 178–187. 6 indexed citations
3.
Burgess, Lesley, et al.. (2024). Long term efficacy and safety of lerodalcibep in patients with atherosclerotic cardiovascular disease (liberate-CVD). Atherosclerosis. 395. 118513–118513. 2 indexed citations
4.
Raal, Frederick J., Vimal Mehta, Meral Kayıkçıoğlu, et al.. (2023). Abstract 15073: Response to PCSK9 Inhibition in Homozygous Familial Hypercholesterolemia Patients is Variable in Different Regions of the World and According to Age. Circulation. 148(Suppl_1). 2 indexed citations
5.
Hess, David C., Lawrence R. Wechsler, Wayne M. Clark, et al.. (2017). Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology. 16(5). 360–368. 266 indexed citations
6.
Sanyal, Arun J., Vlad Ratziu, Zachary Goodman, et al.. (2016). 507 APRI and FIB-4 Index Scores Can Enrich for Subjects With Fibrotic Non-Alcoholic Steatohepatitis (NASH) in Clinical Trials - The CENTAUR Trial Data. Gastroenterology. 150(4). S1037–S1038. 1 indexed citations
7.
Isaacsohn, Jonathan L., et al.. (2003). The challenges of conducting clinical endpoint studies. Current Atherosclerosis Reports. 5(1). 11–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kate Xie Breakdown of academic impact, for papers by Pilar Piñero Breakdown of academic impact, for papers by Magdalena Carmona Breakdown of academic impact, for papers by Julia Billigen Breakdown of academic impact, for papers by Maurício Friedrich Breakdown of academic impact, for papers by Xiaopei Xi Breakdown of academic impact, for papers by Kelsey Duncan Breakdown of academic impact, for papers by Tongchao Geng Breakdown of academic impact, for papers by Katsuhiko Maruichi Breakdown of academic impact, for papers by Mohammad Reza Motamed
Rankless by CCL
2026